Searchable abstracts of presentations at key conferences in endocrinology

ea0003p236 | Signalling | BES2002

Do inhibitors of NAD(P)H oxidase improve endothelial function in rat and human arteries?

Hamilton C , Brosnan M , Dominiczak A

Background. The endothelial dysfunction prevalent in hypertension and diabetes is associated with an imbalance in the levels of nitric oxide (NO) and superoxide (SO). NAD(P)H oxidase is the predominant source of SO in the vasculature. Objectives. To manipulate levels of SO using the NAD(P)H oxidase inhibitors, apocynin, phenyl arsine oxide (PAO) and 4(2aminoethyl)benzenesulfonyl fluoride (AEBSF) and relate this to NO bioavailability. Methods. NO bioavailability was compared in...

ea0056p777 | Pituitary - Basic | ECE2018

Functional analysis of aryl hydrocarbon receptor (AHR) polymorphisms in pituitary adenomas (PAs) in the presence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)

Debattista Jessica , Formosa Robert , Vassallo Josanne

Background: PAs are the most frequent pituitary neoplasms, however molecular pathogenesis is largely unknown. The AHR is a ligand-activated transcription factor that regulates expression of various genes that mediate cellular response to xenobiotics. The exact functional role of two AHR single nucleotide polymorphisms (SNPs); Arginine554Lysine (Arg554Lys) and Valine570Isoleucine (Val570Ile) has not yet been established, however studies suggest that these mutations might increa...

ea0047oc45 | Innovative Theranostics | Theranostics2016

Glioma tumors grade II/III – local alpha emiters targeted therapy with 213Bi-DOTA-substance P

Krolicki Leszek LK , Morgenstern Alfred AM , Kunikowska Jolanta JK , Koziara Henryk HK , Bartosz Krolicki BK , Jakucinski Maciej MJ , Pawlak Dariusz DP , Apostolidis Constantinos CA , Bruchertseifer Frank FB

Gliomas are a highly heterogeneous group of brain tumours that are refractory to treatment, and highly invasive. The treatment and prognosis depend upon the tumor grade. Treatment of Grade II/III gliomas typically consists of maximal safe resection, followed by external beam radiation therapy. Although less aggressive than GBM, mortality is high with a 5-year survival rate of only 25.9%. Glioma tumors has been demonstrated NK-1 receptor system and substance P can be used as a ...

ea0073aep577 | Reproductive and Developmental Endocrinology | ECE2021

A novel heterozygous mutation in CYP19A1 Gene c.456_462del p.(Ser153Profs*24) in a girl with aromatase deficiency

Isabel Inácio , Mafalda Simões , Leitão Martins Vânia , Geraldes Fernanda , Cardoso Rita , Serra-Caetano Joana , Dinis Isabel , Mirante Alice

BackgroundAromatase deficiency is an extremely rare autosomal recessive condition due to mutations on CYP19A1 gene. Despite the size and complexity of this gene, only about 40 cases with aromatase deficiency have been reported.Case reportThe patient was born at term from non-consanguineous parents. Maternal signs of virilization were verified during third trimester (deep voice, acne on arms and face ...

ea0090p387 | Endocrine-related Cancer | ECE2023

Don’t let your guard down – aggressive, hereditary paraganglioma associated with SDHD gene nonsense variant: c.33C>A (p.(Cys11Ter))

Szatko Alicja , Leszczynska Dorota , Woźniak Beata , Papierska Lucyna , Zgliczyński Wojciech , Glinicki Piotr

Introduction: Paragangliomas belong to the neuroendocrine tumours arising from autonomic nervous system. Various localizations, symptoms that can mimic a wide range of diseases and often unpredictable ability to metastasize are the reasons why paragangliomas pose a significant diagnostic challenge. More than one third of paragangliomas is associated with germline mutations –succinate dehydrogenase (SDH) subunit genes are among the most common susceptibility genes. SDHD wa...

ea0011p462 | Endocrine tumours and neoplasia | ECE2006

Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2

Zatelli MC , Luchin A , pICCIN D , Tagliati F , Bottoni A , Vignali C , Bondanelli M , degli Uberti EC

Medullary thyroid carcinoma (MTC) is a malignant tumour deriving from parafollicular C cells, with a highly chemoresistant phenotype. Failure of medical therapy has been ascribed, at least in part, to multi drug resistance (MDR1) gene over-expression. MDR1 encodes for a transmembrane glycoprotein, P-gp, which hampers intracellular accumulation of cytotoxic drugs. It has been demonstrated that P-gp expression and function depend on cyclo-oxygenase 2 (COX-2) expression, which is...

ea0090ep955 | Thyroid | ECE2023

Oxidative stress and the level of NAD(P)-dependent dehydrogenases of blood neutrophils in patients with compensated and relapse Graves’ hyperthyroidism ongoing thiamazole treatment

Dudina Margarita , Savchenko Andrey , A. Dogadin Sergey , Gvozdev Ivan

Background: Oxidative stress is involved in the pathogenesis of Graves hyperthyroidism (GH) and a disbalance of the cell redox state is associated with thyroid hyperfunction and the reccurence of the disease. Aim: To study the level of reactive oxygen species (ROS) and NAD(P)-dependent dehydrogenases of peripheral blood neutrophils in patients with compensated and relapse GH ongoing thiamazole. Materials and Methods: The study incl...

ea0098c30 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Novel alternate (Alt) response criteria for early outcome prediction in pancreatic (P) neuroendocrine tumors (NETs): utilizing banked imaging and radiomics

Lareef Ishara , Vijayvergia Namrata , Handorf Elizabeth , Kunz Pamela L. , Alkim Emil , Burke Lauren M. , Catalano Paul , Graham Noah , Levin Laura , Li Weier , Meeker Caitlin , Rubin Daniel , Sridharan Anush , O'Dwyer Peter J. , Wong Terence Z. , Anaokar Jordan

Background: Evaluating treatment (Tx) Response in NETs using CT/MRI scans can be difficult. Previous studies, including the E2211, have shown improved progression-free survival (PFS) but no significant difference in Rp as measured by RECIST 1.1 (R1.1) criteria. Therefore, it is difficult to determine Tx effectiveness with short-term imaging, further complicated by differences in imaging protocols and inter-reader variability. Incorporating tumor density, using smaller threshol...

ea0084ps2-10-89 | Nodules & Cancer | ETA2022

Follicular thyroid neoplasm with papillary-like nuclear features (NIFT-P) showed peculiar ultrasonographic features compared to follicular variant of papillary thyroid carcinoma (FV-PTC), follicular carcinoma (FTC) and follicular adenoma (FA)

De Napoli Luigi , Matrone Antonio , Gambale Carla , Pieroni Erica , Boni Giulia , Aghababyan Aleksandr , Enrico Ambrosini Carlo , Torregrossa Liborio , Basolo Fulvio , Materazzi Gabriele , Elisei Rossella

Background: Up to 2016, NIFT-P was considered a non-invasive encapsulated follicular variant of papillary thyroid carcinoma (FV-PTC) and was reclassified and downgraded to a pre-malignant lesion. However, if these nodules have peculiar ultrasonographic features able to pre-operatively suggest their histology is still a matter of discussion. We evaluated a large series of NIFT-P, FV-PTC, FTC, and FA to characterize their ultrasonographic features.Methods:...

ea0019p212 | Neuroendocrinology and behaviour | SFEBES2009

Stimulation of PKCβII -dependent ERK1/2 signalling by endokinin B and substance P may cause gene transcription via the tachykinin NK1 receptor in astrocytoma cells

Newton S , Walker A , Page N

Endokinin B (EKB) is a recently identified tachykinin whose role is not yet fully understood. EKB displays equivalent affinity for the three tachykinin receptors as substance P (SP) which it is often found co-expressed with. SP has been implicated in a variety of neuroendocrinological responses including stress regulation, and affective and anxiety-related behaviours. An important aspect, therefore, is to dissect a distinct role for EKB from that of SP. Here, we have attempted...